Skip to main content
. 2017 Nov 30;8(67):111309–111317. doi: 10.18632/oncotarget.22785

Table 2. First site of progression.

First site of failure Treatment
With early RT (n=42) (%) Without early RT (n=53) (%) P value
0.210
Isolated intracranial failure 10(24) 19(36) 0.206
Both intracranial and extracranial failure 14(33) 20(38) 0.657
Isolated extracranial failure 18(43) 14(26) 0.092